Table 2. Univariate Cox regression analyses of prognosis of OS.

Characteristic	HR (95% CI)	P
Age (<65, ≥65)	1.119 (0.799–1.569)	0.512
Gender (male, female)	1.367 (0.956–1.952)	0.086
Smoking history (no, yes)	1.245 (0.883–1.754)	0.211
Drinking history (no, yes)	1.308 (0.880–1.943)	0.184
Type 2 diabetes (no, yes)	0.930 (0.473–1.829)	0.833
Hypertension (no, yes)	0.807 (0.541–1.204)	0.293
Tumor size (<3 cm, ≥3 cm)	1.249 (0.864–1.806)	0.237
Lymph node metastasis (no, yes)	2.098 (1.473–2.990)	0.00004
Pathological type (adenocarcinoma, non-adenocarcinoma)	1.293 (0.915–1.826)	0.145
Degree of differentiation (well + moderate, poor)	1.816 (1.261–2.615)	0.001
Pathological stage (IA–IIB, IIIA–IV)	1.871 (1.336–2.622)	0.0003
HALP (<48.0, ≥48.0)	0.531 (0.379–0.744)	0.0002
LMR (<6.3, ≥6.3)	0.482 (0.312–0.744)	0.001

P<0.05 was statistically significant. OS, overall survival; HALP, hemoglobin, albumin, lymphocyte, and platelet; LMR, lymphocyte-to-monocyte ratio.